Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03177577 · ClinicalTrials.gov registry record · NA
Strengthening of the First Dorsal Interosseous for Thumb Carpometacarpal Osteoarthritis
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 160
- Enrollment target
NCT03177577: Completed NA study, sponsored by Massachusetts General Hospital.
NCT03177577 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 160 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03177577, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
Study Summary
To determine the effect of first dorsal interosseus (FDI) strengthening in patients with thumb carpometacarpal (CMC) osteoarthritis.
Interventions
- DEVICE Splint
- DEVICE Splint with strengthening exercises
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2016-12-29 |
| Est. Completion | 2025-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03177577
The ClinicalTrials.gov registry entry for NCT03177577 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Splint is the first listed.
NCT03177577 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03177577 about?
NCT03177577 is a clinical study titled "Strengthening of the First Dorsal Interosseous for Thumb Carpometacarpal Osteoarthritis". To determine the effect of first dorsal interosseus (FDI) strengthening in patients with thumb carpometacarpal (CMC) osteoarthritis.
What is the current status of trial NCT03177577?
This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2016-12-29. Estimated completion is 2025-09.
What interventions are being tested in trial NCT03177577?
The interventions under investigation include: Splint (DEVICE), Splint with strengthening exercises (DEVICE).
Who is sponsoring clinical trial NCT03177577?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.